GRAIL Competitors, Revenue, Alternatives and Pricing

Claim your profile


Total Funding:$2B
Lead Investor(s):Ally Bridge Group

City Ranking

Industry Ranking

State Ranking

Growjo 10k Ranking

Estimated Revenue & Financials

  • GRAIL's estimated annual revenue is currently $95M per year.(?)
  • GRAIL received $300.0M in venture funding in May 2018.
  • GRAIL's estimated revenue per employee is $155,000
  • GRAIL's total funding is $2B.

Employee Data

  • GRAIL has 613 Employees.(?)
  • GRAIL grew their employee count by 44% last year.
  • GRAIL currently has 116 job openings.

GRAIL is a life sciences company whose mission is to detect cancer early, when it can be cured. GRAIL is using the power of high-intensity sequencing, population-scale clinical trials, and state of the art Computer Science and Data Science to enhance the scientific understanding of cancer biology and develop blood tests for early-stage cancer detection. The company has secured over $1B in venture funding led by ARCH Venture Partners and including Amazon, Bezos Expeditions, Bill Gates, Bristol-Myers Squibb, Celgene, GV, Illumina, Johnson & Johnson Innovation, Merck, McKesson Ventures, Sutter Hill Ventures, Tencent, Varian Medical Systems, and other financial partners. If you're ready to join a mission with meaning, bring your passion to GRAIL. Together we will make history in the fight against cancer.

keywords:Biotechnology, Life Sciences, Healthcare, Diagnostics, Medical Technologies, Medical Device